Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway

Journal of Molecular Histology

Volumn 46, Issue 2, 2015, Pages 157-171

  Shu, Jing ^a   Huang, Mengge ^b   Tian, Qiang ^b   Shui, Qinglin ^b   Zhou, Yujian ^a   Chen, Junxia ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

AKT mTOR signaling pathway; Angiogenin; Apoptosis; Bladder cancer cells

Indexed keywords

ANGIOGENIN; CD31 ANTIGEN; GSK 3BETA PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN; PROTEIN KINASE B; S6 KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MTOR PROTEIN, HUMAN; PANCREATIC RIBONUCLEASE; TARGET OF RAPAMYCIN KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER CELL LINE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ASSAY; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CHROMATIN CONDENSATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS; MOUSE; MTT ASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BLADDER TUMOR; CANCER TRANSPLANTATION; CELL SHAPE; ENZYMOLOGY; GENETICS; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-AKT; RIBONUCLEASE, PANCREATIC; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; URINARY BLADDER NEOPLASMS;

EID: 84925511313     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-014-9608-x     Document Type: Article

References (33)

1. Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ et al (2013) Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis 4:e875
2. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF et al (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480–5486
3. Ibaragi S, Yoshioka N, Li S, Hu MG, Hirukawa S, Sadow PM et al (2009a) Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription. Clin Cancer Res 15:1981–1988
4. Ibaragi S, Yoshioka N, Kishikawa H, Hu JK, Sadow PM, Li M et al (2009b) Angiogenin-stimulated rRNA transcription is essential for initiation and survival of AKT-induced prostate intraepithelial neoplasia. Mol Cancer Res 7:415–424
5. Ivanov P, Emara MM, Villen J, Gygi SP, Anderson P (2011) Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell 43:613–623
6. Janku F, Wheler JJ, Westin SN, Moulder SL, Naing A, Tsimberidou AM et al (2012) PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. J Clin Oncol 30:777–782
7. Janku F, Wheler JJ, Naing A, Falchook GS, Hong DS, Stepanek VM et al (2013) PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials. Cancer Res 73:276–284
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA: A Cancer J Clin 61:69–90
9. Kieran D, Sebastia J, Greenway MJ, King MA, Connaughton D, Concannon CG (2008) Control of motoneuron survival by angiogenin. J Neurosci 28:14056–14061
10. Kim HM, Kang DK, Kim HY, Kang SS, Chang SI (2007) Angiogenin-induced protein kinase B/Akt activation is necessary for angiogenesis but is independent of nuclear translocation of angiogenin in HUVE cells. Biochem Biophys Res Commun 352:509–513
11. Li S, Hu GF (2010) Angiogenin-mediated rRNA transcription in cancer and neurodegeneration. Int J Biochem Mol Biol 1:26–35
12. Li S, Hu GF (2012) Emerging role of angiogenin in stress response and cell survival under adverse conditions. J Cell Physiol 227:2822–2826
13. Li S, Ibaragi S, Hu GF (2011) Angiogenin as a molecular target for the treatment of prostate cancer. Curr Cancer Ther Rev 7:83–90
14. Li L, Pan XY, Shu J, Jiang R, Zhou YJ, Chen JX (2014) Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway. Biochimie 103:89–100
15. Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8:627–644
16. Luo F, Burke K, Kantor C, Miller RH, Yang Y (2014) Cyclin-dependent kinase 5 mediates adult OPC maturation and myelin repair through modulation of akt and gsk-3β signaling. J Neurosci 34:10415–10429
17. Malla R, Gopinath S, Alapati K, Gondi CS, Gujrati M, Dinh DH et al (2010) Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One 5:e13731
18. Muramatsu M, Yamamoto S, Osawa T, Shibuya M (2010) Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth. Cancer Res 70:8211–8221
19. Nilsson UW, Abrahamsson A, Dabrosin C (2010) Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo. Clin Cancer Res 16:3659–3669
20. Paudel N, Sadagopan S, Chakraborty S, Sarek G, Ojala PM, Chandran B (2012) Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions. J Virol 86:5974–5991
21. Pizzo E, Sarcinelli C, Sheng J, Fusco S, Formiggini F, Netti P et al (2013) Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival. J Cell Sci 126:4308–4319
22. Reikvam H, Nepstad I, Bruserud Ø, Hatfield KJ (2013) Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells. Oncotarget 4:830–843
23. Rosser CJ, Ross S, Chang M, Dai Y, Mengual L, Zhang G et al (2013) Multiplex protein signature for the detection of bladder cancer in voided urine samples. J Urol 190:2257–2262
24. Sheng J, Yu W, Gao X, Xu Z, Hu GF (2014) Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter. J Cell Physiol 229:521–529
25. Suriano F, Altobelli E, Sergi F, Buscarini M (2013) Bladder cancer after radiotherapy for prostate cancer. Rev Urol 15:108–112
26. Trouillon R, Kang DK, Park H, Chang SI, O’Hare D (2010) Angiogenin induces nitric oxide synthesis in endothelial cells through PI-3 and Akt kinases. Biochemistry 49:3282–3288
27. Urquidi V, Goodison S, Kim J, Chang M, Dai Y, Rosser CJ (2012) Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection. Urology 79(1185):e1–6
28. Wei S, Gao X, Du J, Su J, Xu Z (2011) Angiogenin enhances cell migration by regulating stress fiber assembly and focal adhesion dynamics. PLoS One 6:e28797
29. Xiong D, Liou Y, Shu J, Li D, Zhang L, Chen J (2014) Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway. Exp Mol Pathol 96:411–421
30. Yao X, Li D, Xiong DM, Li L, Jiang R, Chen JX (2013) A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells. Cell Tissue Res 353:409–423
31. Yoshioka N, Wang L, Kishimoto K, Tsuji T, Hu GF (2006) A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci USA 103:14519–14524
32. Yuan Y, Wang F, Liu XH, Gong DJ, Cheng HZ, Huang SD (2009) Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis. Lung Cancer 66:28–36
33. Zhu J, Sheng J, Dong H, Kang L, Ang J, Xu Z (2013) Phospholipid scramblase 1 functionally interacts with angiogenin and regulates angiogenin-enhanced rRNA transcription. Cell Physiol Biochem 32:1695–1706